Introduction to COX inhibitors

被引：13
作者：
Biava, Mariangela [1 ]
机构：
[1] Sapienza Univ, Dipartimento Chim & Tecnol Farmaco, Ple A Moro 5, I-00185 Rome, Italy
来源：
FUTURE MEDICINAL CHEMISTRY | 2018年 / 10卷 / 15期
关键词：
SELECTIVE-INHIBITION; CYCLOOXYGENASE; 2; INFLAMMATION; DERIVATIVES; PREVENTION; NSAIDS; RISK;
D O I：
10.4155/fmc-2018-0159
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：1737 / 1740
页数：4
相关论文
共 18 条
  • [11] Thiazoles and Thiazolidinones as COX/LOX Inhibitors
    Liaras, Konstantinos
    Fesatidou, Maria
    Geronikaki, Athina
    [J]. MOLECULES, 2018, 23 (03):
  • [12] Induction of COX-2/PGE2/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: Role of TLR4-dependent NADPH oxidase activation
    Lin, Chih-Chung
    Lee, I-Ta
    Yang, Ya-Lin
    Lee, Chiang-Wen
    Kou, Yu Ru
    Yang, Chuen-Mao
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2010, 48 (02) : 240 - 254
  • [13] Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
    McGettigan, Patricia
    Henry, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13): : 1633 - 1644
  • [14] NSAIDs and cardiovascular disease
    Patrignani, Paola
    Capone, Marta L.
    Tacconelli, Stefania
    [J]. HEART, 2008, 94 (04) : 395 - 397
  • [15] Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI200113418
  • [16] Role of Cox-2 in Vascular Inflammation: An Experimental Model of Metabolic Syndrome
    Renna, Nicolas F.
    Diez, Emiliano R.
    Lembo, Carina
    Miatello, Roberto M.
    [J]. MEDIATORS OF INFLAMMATION, 2013, 2013 : 513251
  • [17] Targeting Inflammation in Cancer Prevention and Therapy
    Todoric, Jelena
    Antonucci, Laura
    Karin, Michael
    [J]. CANCER PREVENTION RESEARCH, 2016, 9 (12) : 895 - 905
  • [18] Zito W., 2013, FOYES PRINCIPLES MED, P1021
12